Immunologic Deficiency Syndromes
"Immunologic Deficiency Syndromes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.
| Descriptor ID |
D007153
|
| MeSH Number(s) |
C20.673
|
| Concept/Terms |
Immunologic Deficiency Syndromes- Immunologic Deficiency Syndromes
- Deficiency Syndromes, Immunologic
- Immunological Deficiency Syndromes
- Deficiency Syndrome, Immunological
- Deficiency Syndromes, Immunological
- Immunological Deficiency Syndrome
- Syndrome, Immunological Deficiency
- Syndromes, Immunological Deficiency
- Deficiency Syndrome, Immunologic
- Syndrome, Immunologic Deficiency
- Syndromes, Immunologic Deficiency
- Immunologic Deficiency Syndrome
Antibody Deficiency Syndrome- Antibody Deficiency Syndrome
- Deficiency Syndromes, Antibody
- Antibody Deficiency Syndromes
- Deficiency Syndrome, Antibody
- Syndrome, Antibody Deficiency
- Syndromes, Antibody Deficiency
|
Below are MeSH descriptors whose meaning is more general than "Immunologic Deficiency Syndromes".
Below are MeSH descriptors whose meaning is more specific than "Immunologic Deficiency Syndromes".
This graph shows the total number of publications written about "Immunologic Deficiency Syndromes" by people in this website by year, and whether "Immunologic Deficiency Syndromes" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 2 | 0 | 2 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunologic Deficiency Syndromes" by people in Profiles.
-
Influenza epidemics: The role of allergists-immunologists. Ann Allergy Asthma Immunol. 2021 04; 126(4):350-356.
-
A Phased Approach to Resuming Suspended Allergy/Immunology Clinical Services. J Allergy Clin Immunol Pract. 2020 Jul - Aug; 8(7):2125-2134.
-
Comment on "Incidence of pneumocystosis among patients exposed to immunosuppression". J Am Acad Dermatol. 2019 08; 81(2):e47.
-
Efficacy and Safety of Human Intravenous Immunoglobulin 10% (Panzyga?) in Patients with Primary Immunodeficiency Diseases: a Two-Stage, Multicenter, Prospective, Open-Label Study. J Clin Immunol. 2017 Aug; 37(6):603-612.
-
Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex? 10% Versus Gammaplex? 5% in Subjects with Primary Immunodeficiency. J Clin Immunol. 2017 Apr; 37(3):301-310.
-
Validation of a Method to Identify Immunocompromised Patients with Severe Sepsis in Administrative Databases. Ann Am Thorac Soc. 2016 Feb; 13(2):253-8.
-
Recipient Myd88 Deficiency Promotes Spontaneous Resolution of Kidney Allograft Rejection. J Am Soc Nephrol. 2015 Nov; 26(11):2753-64.
-
Chronic rhinosinusitis and age: is the pathogenesis different? Expert Rev Anti Infect Ther. 2013 Oct; 11(10):1029-40.
-
Progressive multifocal leukoencephalopathy in a patient without immunodeficiency. Neurology. 2011 Jul 19; 77(3):297-9.
-
Efficacy, pharmacokinetics, safety, and tolerability of Flebogamma 10% DIF, a high-purity human intravenous immunoglobulin, in primary immunodeficiency. J Clin Immunol. 2010 Mar; 30(2):321-9.